Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II adjuvant S-1 with concurrent radiotherapy and consolidation S-1 after radical resection for periampullary carcinoma
ChiCTR-TNC-11001362Phase 2Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in Periampullary Carcinoma, sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: disease-free survival and overall survival. Started May 2011; status: recruiting.
02
Drugs
tegafur
03
Conditions
Periampullary Carcinoma
Beyond the preview
Go deeper on ChiCTR-TNC-11001362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001362.